These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29061814)

  • 1. Cycloartobiloxanthone Inhibits Migration and Invasion of Lung Cancer Cells.
    Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6311-6319. PubMed ID: 29061814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batatasin III Inhibits Migration of Human Lung Cancer Cells by Suppressing Epithelial to Mesenchymal Transition and FAK-AKT Signals.
    Pinkhien T; Petpiroon N; Sritularak B; Chanvorachote P
    Anticancer Res; 2017 Nov; 37(11):6281-6289. PubMed ID: 29061811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phoyunnanin E inhibits migration of non-small cell lung cancer cells via suppression of epithelial-to-mesenchymal transition and integrin αv and integrin β3.
    Petpiroon N; Sritularak B; Chanvorachote P
    BMC Complement Altern Med; 2017 Dec; 17(1):553. PubMed ID: 29284478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of artonin e on migration and invasion capabilities of human lung cancer cells.
    Plaibua K; Pongrakhananon V; Chunhacha P; Sritularak B; Chanvorachote P
    Anticancer Res; 2013 Aug; 33(8):3079-88. PubMed ID: 23898063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Millettocalyxin B Inhibits Migratory Behavior of Lung Cancer Cells
    Lafauy P; Silapech A; Aksorn N; Sritularak B; Chanvorachote P
    Anticancer Res; 2021 Aug; 41(8):3843-3849. PubMed ID: 34281844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ephemeranthol A Suppresses Epithelial to Mesenchymal Transition and FAK-Akt Signaling in Lung Cancer Cells.
    Nonpanya N; Prakhongcheep O; Petsri K; Jitjaicham C; Tungsukruthai S; Sritularak B; Chanvorachote P
    Anticancer Res; 2020 Sep; 40(9):4989-4999. PubMed ID: 32878787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
    Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
    Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide increases the migratory activity of non-small cell lung cancer cells via AKT-mediated integrin αv and β1 upregulation.
    Saisongkorh V; Maiuthed A; Chanvorachote P
    Cell Oncol (Dordr); 2016 Oct; 39(5):449-462. PubMed ID: 27376838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cycloartobiloxanthone Induces Human Lung Cancer Cell Apoptosis
    Losuwannarak N; Sritularak B; Chanvorachote P
    In Vivo; 2018; 32(1):71-78. PubMed ID: 29275301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enterolactone alters FAK-Src signaling and suppresses migration and invasion of lung cancer cell lines.
    Chikara S; Lindsey K; Borowicz P; Christofidou-Solomidou M; Reindl KM
    BMC Complement Altern Med; 2017 Jan; 17(1):30. PubMed ID: 28068967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisplatin at sub-toxic levels mediates integrin switch in lung cancer cells.
    Maiuthed A; Chanvorachote P
    Anticancer Res; 2014 Dec; 34(12):7111-7. PubMed ID: 25503138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
    Putri HE; Sritularak B; Chanvorachote P
    Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine Induces G0/G1 Cell Cycle Arrest and Inhibits Migration through Integrin αv, β3, and FAK/Akt/c-Myc Signaling Pathway.
    Meisaprow P; Aksorn N; Vinayanuwattikun C; Chanvorachote P; Sukprasansap M
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
    Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
    Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norcycloartocarpin targets Akt and suppresses Akt-dependent survival and epithelial-mesenchymal transition in lung cancer cells.
    Nonpanya N; Sanookpan K; Joyjamras K; Wichadakul D; Sritularak B; Chaotham C; Chanvorachote P
    PLoS One; 2021; 16(8):e0254929. PubMed ID: 34383763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP.
    Lv XQ; Qiao XR; Su L; Chen SZ
    Acta Pharmacol Sin; 2016 Dec; 37(12):1574-1586. PubMed ID: 27593221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bufalin inhibits gefitinib resistant NCI-H460 human lung cancer cell migration and invasion in vitro.
    Huang AC; Yang MD; Hsiao YT; Lin TS; Ma YS; Peng SF; Hsia TC; Cheng YD; Kuo CL; Chung JG
    J Ethnopharmacol; 2016 Dec; 194():1043-1050. PubMed ID: 27833027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3,4-Dihydroxybenzalactone Suppresses Human Non-Small Cell Lung Carcinoma Cells Metastasis via Suppression of Epithelial to Mesenchymal Transition, ROS-Mediated PI3K/AKT/MAPK/MMP and NFκB Signaling Pathways.
    Chao W; Deng JS; Li PY; Liang YC; Huang GJ
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28350337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.